Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Curaleaf Holdings Inc T.CURA

Alternate Symbol(s):  CURLF

Curaleaf Holdings, Inc. is an international provider of consumer cannabis products. The Company and its brands, including Curaleaf, Select, Grassroots, JAMS, Find and Zero Proof provide selection and accessibility across the medical and adult use markets. It operates in approximately 17 states and owns and operates 147 dispensaries and 21 cultivation sites with a focus on states, including... see more

TSX:CURA - Post Discussion

Curaleaf Holdings Inc > CURA: International Revenue
View:
Post by MasterPeace on Nov 12, 2024 8:34am

CURA: International Revenue

DJ Curaleaf On Track for $100 Million in Overseas Revenue This Year -- Market Talk, from 1:21PM ET on Thursday Nov 07, 2024 by Dow Jones

1:21PM ET on Thursday Nov 07, 2024 by Dow Jones
Companies Mentioned: CURA

1321 ET - Curaleaf Holdings is on track to eclipse $100 million in international revenue this year, with a vision for more growth coming in Germany, the U.K. and Poland, Alliance Global Partners analyst Aaron Grey says in a research note.

The cannabis company remains the largest player in terms of sales outside of North America, which were up 17% quarter-to-quarter in 3Q and came roughly in line with Grey's estimates, he says. International sales should help keep Curaleaf's top line moving higher following the disappointing defeat of a recreational cannabis legalization vote in Florida this week, Grey says.(dean.seal@wsj.com)
Be the first to comment on this post
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities